Ki67 ≥70%, bulky tumor ≥7.5 cm, meningeal involvement, and PET0–PET4 ΔSUVmax <71% were identified as independent predictors of relapse and, except for bulky tumor, of OS in patients who were newly diagnosed with DLBCL. Here, MKI67 is linked to diffuse large B-cell lymphoma.